Aims-To examine the expression of CD44 variant exon 9 in early colorectal malignancies. Methods-Formalin fixed, paraffin wax embedded tissue sections from 30 cases of tubular adenoma and 35 cases of adenoma with focal carcinoma of the colon were examined immunohistochemically using a monoclonal antibody (MAb 11.24) directed against CD44-9v. Results-In the normal colorectal mucosa immunoreactivity was confined to the basal part of the crypts and was expressed in less than 10% of crypt cells. CD44-9v was expressed in the superficial part of tubular adenoma with mild atypia in 67% ofthe cases and in 19% ofthe tumour cells. The immunoreactivity was observed along the basement membrane in mild atypia, as in the non-neoplastic crypts. In the course of progression to severe atypia the spatial polarity of immunoreactivity was lost, and the extent of CD44-9v expression increased in intensity and in the percentage of positive cases Several CD44v isoforms are also overexpressed in human tumours, including colorectal carcinomas.8 11-16 Regarding colorectal tumorigenesis, there are two theories which have been the subject of much discussion: the de novo carcinogenesis theory2 17 18 and the adenoma-carcinoma sequence theory.`-21 Recently, it has been reported that expression of CD44-6v, which is a human homologue of the rat metastasis associated variant of CD44, is largely restricted to the advanced stages of tumour development and is also found at a greater incidence and intensity in metastatic than in non-metastatic carcinomas.'6 However, little is known about the expression of exon 9v in colonic adenomas and cancers. The present study was conducted to investigate the expression of CD44-9v on human colonic polyps with particular attention to early colonic carcinogenesis from the standpoint of the multistep carcinogenesis model.22
CD44 is a ubiquitous transmembrane glycoprotein that has putative functions in cell-cell and cell-matrix adhesion, participating in lymphocyte homing, haemopoiesis, cell migration, and metastasis.1A In addition to the smallest standard CD44 isoform (CD44s), several larger variant isoforms are generated by alternative splicing of at least 10 exons inserted at the extracellular domain of the protein. 5 In contrast to CD44s, limited data are available about the expression and function of CD44 variants (CD44v).
In normal human tissues most epithelia express variant exon 9 (exon 9v), but much fewer express variant exons 4 or 6. The highest expression of CD44v is observed in the basal cells of stratified squamous epithelium and generative cells of glandular epithelium. Exon 6v is expressed only in squamous and glandular epithelia.6 CD44-9v is very weakly expressed on leucocytes, and CD44-6v and -4v are virtually absent. However, exons 9v and 6v are transiently upregulated on T cells after mitogenic stimulation. 6 8 In rats, expression of exon 6v conferred metastatic potential to nonmetastasising pancreatic carcinoma cells. 9 10 Several CD44v isoforms are also overexpressed in human tumours, including colorectal carcinomas. 8 11-16 Regarding colorectal tumorigenesis, there are two theories which have been the subject of much discussion: the de novo carcinogenesis theory2 17 18 and the adenoma-carcinoma sequence theory.`-21 Recently, it has been reported that expression of CD44-6v, which is a human homologue of the rat metastasis associated variant of CD44, is largely restricted to the advanced stages of tumour development and is also found at a greater incidence and intensity in metastatic than in non-metastatic carcinomas.'6 However, little is known about the expression of exon 9v in colonic adenomas and cancers. The present study was conducted to investigate the expression of CD44-9v on human colonic polyps with particular attention to early colonic carcinogenesis from the standpoint of the multistep carcinogenesis model. (fig 1F) . The percentage of positive cells in the carcinomatous lesion was significantly greater than that in the adenomatous lesions with focal carcinoma (p < 0.0001) and that in tubular adenoma with moderate atypia (p < 0.02).
Discussion
Wielenga et all6 have already reported expression of CD44 variant proteins in colorectal carcinomas and adenomatous polyps using frozen sections. In normal colonic epithelium epitopes encoded by exons 7v and 8-10v were weakly expressed and localised to the base of the crypt, similar to expression of CD44s proteins. The other variant CD44 exons (3v-6v) were not expressed. Overexpression of exons 5v and 7-10v was observed ubiquitously in early and large colorectal adenomas and early and advanced carcinomas. Expression of variants containing exon 6v sequences was largely restricted to the advanced tumour stages and was more intense in metastatic than in non-metastatic carcinomas. However, a detailed histology is difficult to determine using frozen sections only, and Wielenga et al did not use a monoclonal antibody specific to exon 9v protein alone. '6 In the present study, we analysed formalin fixed, paraffin wax embedded tissue sections from colorectal polyps resected by endoscopic polypectomy. In the preliminary experiment we tested three monoclonal antibodies recognising epitopes in the exon 4v (MAb 1 1.10), 6v (MAb 11.31) and 9v encoded regions (MAb 11.24) of CD44v.' Of these, only MAb 11.24, recognising the exon 9v product, stained paraffin wax sections, after pretreatment in a microwave oven. Using this monoclonal antibody, staining achieved in paraffin wax sections of human stratified squamous epithelium and colonic mucosa was comparable with that in frozen sections.
In colorectal tubular adenomas CD44-9v was expressed more strongly in mild than moderate atypia, though not significantly. The expression pattern in adenomas was similar to that in normal colorectal epithelium, showing the regular distribution along the basement membrane. In crypts with severe atypia expression of CD44-9v was no longer polar, and the intensity of staining and the percentage of positive cells increased. Furthermore, analysis of five cases of advanced colorectal cancer revealed intense expression of exon 9v in an average of 66% of cancer cells (data not shown).
Expression of exon 9v was also observed in 67% of cases of tubular adenoma with mild atypia. These data suggest that this variant protein may be overexpressed at the very early stages of colorectal cancer, as observed for the CD44s and exon 7v, 8-10v proteins'3 16 and becomes more widespread at the more advanced stages, as seen for exon 6v protein. '6 Two of the cases of adenoma with focal carcinoma did not express CD44-9v in the adenomatous and carcinomatous lesions, although the surrounding normal crypt bases stained positively. This suggests that adenomas may progress to cancer without expressing exon 9v. Further studies are required for confirmation of this point.
In summary, CD44-9v may be overexpressed at the early stages of colorectal tumorigenesis and the level of expression increases throughout the course of the disease. 
